Main > A1. CORP. INDEX. En-Ez > Exelixis/P C2
This data is not available for free
Exelixis/P C2's subsections
2002. 10.14.2002. (Parent of)
2002. 11.04.2002. (GSK)
2003. 03.31.2003. (Oncology)
2003. 04.21.2003. (Exec.)
2003. 04.21.2003. (Focus)
2003. 07.28.2003. (Exec.)
2003. 07.28.2003. (Oncology)
2005. 06.20.2005. (Helsinn Health)
2005. 12.22.2005. (Wyeth)
2006. 03.06.2006. (Exec. VP of)
2006. 03.20.2006. (Cardio.>Sankyo)
2006. 12.18.2006. (BMS>Onco.)
2007. 01.03.2007. (Onco.>XL-518)
2007. 01.22.2007. VP Medicinal
2008. 01.22.2008. (BMS)
2008. 03.14.2008. (Genentech)
2008. 05.26.2008. (CFO)
2008. 06.27.2008. (GSK)
2009. 02.23.2009. (Pres. Of R&D)
2010. 06.21.2010. Onco.>PI3K Inh.
2010. 06.30.2010. CEO
2010. 10.11.2010. (BMS)
2011. 06.04. Ovarian C.
2011. 12.21. Merck USA
2012. 01.20. Liver C.
2012. 03.05. Prostate C.
2014. 03.25. Thyroid C.
2014. 11.04. NSCLC
2014. 12.01. Prostate C.
2015. 11.25. Melanoma
2016. 02.29. Ipsen
2016. 04.25. Kidney C.
2019. 01.14. Liver C.
2019. 07.31. Aurigene
2019. 11.12. Ipsen .. CA>OK
2020. 11.27. Liver C.
2021. 01.22. Kidney C.
2021. 05.04. Onco.>GamaMabs>Acq.
2022. 05.03. Onco.>Thyroid C.>EU>OK
Patents
Web-Site
Z - OK
Exelixis/P C2's products
This section has no products